Contribution of capecitabine for therapy of patients with gastroesophageal cancer: an update of recent phase III results

BACKGROUND: Capecitabine, an orally administered fluoropyrimidines, is widely used in the treatment of multiple malignancies. It has been extensively evaluated in patients with gastroesophageal carcinoma. Since recent reviews have discussed phase I/II trials (Cancer 107:221–231, 2006; Drugs 67:601–6...

Descripción completa

Detalles Bibliográficos
Autores principales: Cen, Putao, Tetzlaff, Eric D, Ajani, Jaffer A
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2008
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2503649/
https://www.ncbi.nlm.nih.gov/pubmed/18728703

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2503649/
https://www.ncbi.nlm.nih.gov/pubmed/18728703

Ejemplares similares